These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 10393980

  • 21. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.
    Serhan CN, Maddox JF, Petasis NA, Akritopoulou-Zanze I, Papayianni A, Brady HR, Colgan SP, Madara JL.
    Biochemistry; 1995 Nov 07; 34(44):14609-15. PubMed ID: 7578068
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4).
    Fierro IM, Kutok JL, Serhan CN.
    J Pharmacol Exp Ther; 2002 Feb 07; 300(2):385-92. PubMed ID: 11805195
    [Abstract] [Full Text] [Related]

  • 24. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release.
    Gronert K, Gewirtz A, Madara JL, Serhan CN.
    J Exp Med; 1998 Apr 20; 187(8):1285-94. PubMed ID: 9547339
    [Abstract] [Full Text] [Related]

  • 25. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing.
    Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K.
    J Exp Med; 2000 Oct 16; 192(8):1197-204. PubMed ID: 11034610
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Agonist-induced lipoxin A4 generation in vitro and in aspirin-sensitive asthmatics: detection by a novel lipoxin A4-ELISA.
    Levy BD, Drazen JM, Serhan CN.
    Adv Exp Med Biol; 1997 Oct 16; 400B():611-5. PubMed ID: 9547611
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
    József L, Zouki C, Petasis NA, Serhan CN, Filep JG.
    Proc Natl Acad Sci U S A; 2002 Oct 01; 99(20):13266-71. PubMed ID: 12235371
    [Abstract] [Full Text] [Related]

  • 33. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
    Parkinson JF.
    Inflamm Allergy Drug Targets; 2006 Apr 01; 5(2):91-106. PubMed ID: 16613568
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 modulate adhesion molecule expression on human leukocytes in whole blood and inhibit neutrophil-endothelial cell adhesion.
    Filep JG, Zouki C, Petasis NA, Hachicha M, Serhan CN.
    Adv Exp Med Biol; 2002 Apr 01; 507():223-8. PubMed ID: 12664589
    [No Abstract] [Full Text] [Related]

  • 36. Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy.
    Brezinski DA, Nesto RW, Serhan CN.
    Circulation; 1992 Jul 01; 86(1):56-63. PubMed ID: 1617790
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells.
    Nascimento-Silva V, Arruda MA, Barja-Fidalgo C, Villela CG, Fierro IM.
    Am J Physiol Cell Physiol; 2005 Sep 01; 289(3):C557-63. PubMed ID: 15901601
    [Abstract] [Full Text] [Related]

  • 40. Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity.
    Maddox JF, Colgan SP, Clish CB, Petasis NA, Fokin VV, Serhan CN.
    FASEB J; 1998 Apr 01; 12(6):487-94. PubMed ID: 9535221
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.